ISSN 1674-3865  CN 21-1569/R
主管:国家卫生和计划生育委员会
主办:中国医师协会
   辽宁省基础医学研究所
   辽宁中医药大学附属医院

Chinese Pediatrics of Integrated Traditional and Western Medicine ›› 2016, Vol. 8 ›› Issue (2): 132-135.doi: 10.3969/j.issn.1674-3865.2016.02.003

Previous Articles     Next Articles

Precise treatment for Kawasaki disease

SUN Le,LI Xuemei,YU Xianyi   

  1. Department of Pediatrics,Shengjing Hospital of China Medical University,Shenyang 110004,China.
  • Online:2016-04-25 Published:2018-11-19

Abstract:
Kawasaki disease(KD)is an acute systemic vasculitis mainly affecting infants and children under 5 years old.Coronary artery lesions(CALs)are the most serious complication.KD is liable to be complicated by coronary artery lesion(CAL)in approximately 25% of untreated KD children.In the acute phase,high dose of intravenous immunoglobulin(IVIG)can relieve symptoms quickly and significantly reduce the risk of CAL.Some adjunctive therapies,including glucocorticoids and infliximab,have been used in treatment of IVIG resistant KD over the past few years.This article also introduces the treatment and management of KD after the acute phase.

Key words: Kawasaki disease, Coronary artery lesion, Gamma globulin, Treatment, Later management, Children